Large Volume Parenteral (LVP) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Market is Segmented By Volume (100ml, 250ml, 500ml, 1000ml, 2000ml), Application, Type of Packaging, And Geography

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global large volume parenteral (lvp) market is projected to expand at a CAGR of 6.1% by 2025. Rising number of surgeries, need for a faster route of drug administration, growing preference for single dose administration of vaccines and drugs, and increase in local manufacturing is expected to drive the market for LVP. 

Increasing patient pool suffering from chronic disease is one of the major drivers in the large volume parenteral market. As per the National Cancer Institute, in 2019, around 1.8 million people diagnosed with cancer in the United States. These patients must need a proper balance of vital nutrients that help in maintaining the hydration level, energy, and strength. Parenteral route of administration helps provide accurate dose of medication as majority of the drug is directly absorbed in circulation, bypassing the gastrointestinal tract. Therefore, target disease act as a vital factor to surge market growth throughout the forecast period.

Moreover, individuals and healthcare authorities are paying extensive focus on limiting the mortality rate due to early birth and are thereby propelling the use of large volume parenteral. Ongoing developments in health insurance and medical technology can also boost the pharma industry by eliminating financial and physical barriers to healthcare access, thereby surging the market growth.

However, challenges in formulation of large volume parenteral such as achieving drug substance and excipient compatibility may restrict the market.

Scope of the Report

As per the scope of the report, large volume parenteral are dosages more than 100 ml volumes of intravenous solutions, commonly prescribed to correct fluid and electrolyte disturbances, nutrition, or to act as a vehicle for administering drug to the body. Commonly used large volume parenteral preparations include infusions of amino acid, mannitol, dextrose, lactated ringer injection, ringer’s injection, and sodium chloride injection. Large volume parenteral market is segmented by volume, application, end-user and geography.

By Volume
100 ml - 250 ml
250 ml - 500 ml
500 ml - 1000 ml
1000 ml - 2000 ml
2000 ml and more
By Application
Therapeutic Injections
Fluid Balance Injections
Nutritious Injections
By Type of Packaging
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Nutritious Injections Segment Dominates the Market and is Expected to Continue the Same during the Forecast Period

  • The nutritious injections by application segment is expected to dominate of the global large volume parenteral market through the forecast period owing to growing applications in the geriatric and pediatric population coupled with its requirement in the management of chronic diseases such as ulcerative colitis and cancer. These patient pool need a continuous nutrition system to fulfill nutrition deficiencies which will pave the way for the segment.
  • In addition, prevalence of malnutrition is high in the developing countries. As per the WHO, around 45% of deaths among children under 5 years of age are linked to undernutrition. Also, 1.9 billion adults are overweight or obese, while 462 million are underweight. The nutrition injections are crucial in terms of nourishment requirements for physical growth to develop a healthy intellectual capacity which is provided through TPN.
  • Furthermore, the American Society for Parenteral and Enteral Nutrition (ASPEN) initiate malnutrition awareness week to educate and raise awareness among patients and healthcare providers. The aforementioned factors bode a well for the segment growth.
trend 1

The North America Dominates the Market and is Expected to Continue the Same during the Forecast Period

North America dominated the overall market over the forecast period owing to presence of high research expenditure by government agencies and private entities in the healthcare sector, technologically advanced medical devices, and collaborations among regulatory authorities, medical device industry, and universities. Approximately 740 units of normal saline are utilized every minute in this region which govern the regional growth of the market for large volume parenterals. 

Moreover, favorable reimbursement policies have led to an increase in the hospital admission that is anticipated to boost the usage rates in this region. The reimbursement scenario is promising for IV nutrition. In the U.S., Medicare covers up to 80% of the expenses of parenteral and enteral nutrition including medical equipment, physician services, and other associated medical services, thereby benefiting the patients. 


Competitive Landscape

The market for large volume parenteral is moderately competitive and consists of the global as well as local players. Due to the technological advancements, small and mid-sized companies are focusing on market penetration to grab the market share. The market is witnessing dynamic merger and acquisition activities. Some of the companies which are currently present in the market are B. Braun Melsungen AG, Baxter Healthcare Corporation, Fresenius Kabi AG, Pfizer, Inc. and BML Parenteral Drugs. For instance, in July 2017, Baxter completes acquisition of Claris injectables. This transaction was expected to strengthen the company’s generic injectable medicines portfolio.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising number of surgeries

      2. 4.2.2 Growing preference for single-dose administration of vaccines and drugs to treat chronic diseases

      3. 4.2.3 Increase in local LVP manufacturing

    3. 4.3 Market Restraints

      1. 4.3.1 Challenges in formulation of LVPs

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Volume

      1. 5.1.1 100 ml - 250 ml

      2. 5.1.2 250 ml - 500 ml

      3. 5.1.3 500 ml - 1000 ml

      4. 5.1.4 1000 ml - 2000 ml

      5. 5.1.5 2000 ml and more

    2. 5.2 By Application

      1. 5.2.1 Therapeutic Injections

      2. 5.2.2 Fluid Balance Injections

      3. 5.2.3 Nutritious Injections

    3. 5.3 By Type of Packaging

      1. 5.3.1 Bottles

      2. 5.3.2 Bags

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Albert David Ltd.

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Baxter Healthcare Corporation

      4. 6.1.4 BML Parenteral Drugs

      5. 6.1.5 Fresenius Kabi AG

      6. 6.1.6 Grifols S.A

      7. 6.1.7 Pfizer, Inc.

      8. 6.1.8 Sichuan Kelun Pharmaceutical Co., Ltd.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Large Volume Parenteral (LVP) Market market is studied from 2018 - 2026.

The Large Volume Parenteral (LVP) Market is growing at a CAGR of 6.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

B. Braun Melsungen AG , Baxter Healthcare Corporation , Fresenius Kabi AG , BML Parenteral Drugs , Pfizer are the major companies operating in Large Volume Parenteral (LVP) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!